Funding for this research was provided by:
Chengdu Science and Technology Bureau (2024-YF05-02565-SN)
the National Natural Science Foundation of China (82360266)
Article History
Received: 17 June 2025
Accepted: 21 January 2026
First Online: 1 March 2026
Declarations
:
: The study design has been approved by the Research Ethics Board of the Third People’s Hospital of Chengdu ([2023]S-228) in 11/21 2023. This study has been registered in the Chinese Clinical Trial Registry (ChiCTR2300079319) in 12/30 2023.
: Not applicable.
: The authors declare that they have no competing interests.